(91) 972 420 1332
info@parthhospital.com
Facebook-f Instagram X-twitter Linkedin Youtube
Parth Hospital

Long-Acting Injectables

  • Home
  • Long-Acting Injectables
What Are Long Acting Injectables?
Long-Acting Injectable Antipsychotics (LAI's) are a special kind of antipsychotic medicine. They’re designed to give you a steady dose of medicine for a long time, without you having to take it every day. Instead of taking pills, you’ll get an injection every few weeks or months, depending on the medicine you’re taking
How are they given?

LAI's are usually given into your muscle, like your buttock or arm. The frequency of injections depends on the medicine you’re taking. It might be every two weeks or every three months.

How Do LAI’s Work?
The medicine in LAI's is wrapped in a special slow-release system. When you get the injection, the medicine starts to release into your bloodstream slowly over time. This means you’ll have a steady level of medicine in your body, and you won’t have the ups and downs that you might get with daily pills

Which patients Can Benefit

LAI’s can be a good option for people who have trouble taking their medication every day. They can also be helpful for people who have side effects that make it difficult to take pills. 

LAI’s can also be a good option for people who are on other medications that need to be taken at specific times.

Long-Acting Injectable Antipsychotics are mainly used for serious psychiatric conditions where taking medicine for a long time is super important. Here are some of the conditions they’re used for:

Schizophrenia Bipolar Disorder Schizoaffective Disorder
Long-Acting Antipsychotics (LAI's) are effective in reducing the negative symptoms associated with schizophrenia, such as hallucinations and delusions, while maintaining stability in mood and behavior. LAI's are instrumental in managing manic episodes and mitigating mood swings. LAI's provide comprehensive treatment for both psychotic and mood-related symptoms in schizoaffective disorder
LAI's demonstrate a high efficacy in preventing relapses and facilitating hospitalizations. They also contribute to maintaining a stable mood for an extended period. By facilitating improved functioning and reducing the frequency of episodes, LAI's contribute to a more manageable condition.
Schizophrenia
  • Long-Acting Antipsychotics (LAI's) are effective in reducing the negative symptoms associated with schizophrenia, such as hallucinations and delusions, while maintaining stability in mood and behavior.
  • LAI's demonstrate a high efficacy in preventing relapses and facilitating hospitalizations.
    •
    Bipolar Disorder
  • LAI's are instrumental in managing manic episodes and mitigating mood swings.
  • They also contribute to maintaining a stable mood for an extended period.
    •
    Schizoaffective Disorder
  • LAI's provide comprehensive treatment for both psychotic and mood-related symptoms in schizoaffective disorder.
  • By facilitating improved functioning and reducing the frequency of episodes, LAI's contribute to a more manageable condition.
    • How do LAI’s help patients with Schizophrenia/ Bipolar Mood Disorder/ Schizo-Affective Mood Disorder
    One of the biggest challenges in treating psychiatric illnesses like schizophrenia or bipolar disorder is making sure you take your medicine every day. Many people forget to take their pills, or they stop taking them because of side effects, stigma, or not understanding their illness well.
    How does LAI use improve outcomes in psychiatric illnesses?
    LAI's make it easier to stick to your medication schedule. You won’t have to worry about taking your pills every day, and you’ll have a steady dose of medicine in your body. This can help you stay on top of your symptoms and avoid relapse.
    What are the Key Outcomes from clinical Studies using LAI’s in such patients worldwide?
    Studies have shown that LAIs can lead to lower rates of hospitalization and relapse. They can also help you control your symptoms and improve your quality of life. LAIs can also help you stay on your medication longer, which is important for your long-term health
    How do LAI’s help patients with Schizophrenia/ Bipolar Mood Disorder/ Schizo-Affective Mood Disorder
    One of the biggest challenges in treating psychiatric illnesses like schizophrenia or bipolar disorder is making sure you take your medicine every day. Many people forget to take their pills, or they stop taking them because of side effects, stigma, or not understanding their illness well.
    How does LAI use improve outcomes in psychiatric illnesses?
    LAI's make it easier to stick to your medication schedule. You won’t have to worry about taking your pills every day, and you’ll have a steady dose of medicine in your body. This can help you stay on top of your symptoms and avoid relapse.
    What are the Key Outcomes from clinical Studies using LAI’s in such patients worldwide?
    Studies have shown that LAIs can lead to lower rates of hospitalization and relapse. They can also help you control your symptoms and improve your quality of life. LAIs can also help you stay on your medication longer, which is important for your long-term health
    How do LAI’s help patients with Schizophrenia/ Bipolar Mood Disorder/ Schizo-Affective Mood Disorder
    One of the biggest challenges in treating psychiatric illnesses like schizophrenia or bipolar disorder is making sure you take your medicine every day. Many people forget to take their pills, or they stop taking them because of side effects, stigma, or not understanding their illness well.
    How does LAI use improve outcomes in psychiatric illnesses?
    LAI's make it easier to stick to your medication schedule. You won’t have to worry about taking your pills every day, and you’ll have a steady dose of medicine in your body. This can help you stay on top of your symptoms and avoid relapse.
    What are the Key Outcomes from clinical Studies using LAI’s in such patients worldwide?
    Studies have shown that LAIs can lead to lower rates of hospitalization and relapse. They can also help you control your symptoms and improve your quality of life. LAIs can also help you stay on your medication longer, which is important for your long-term health

    Now, here are some things to consider before giving LAI's to a patient

    Reason Description
    Poor Adherence History If you’ve had trouble taking your medicine in the past, LAI's might be the best option.
    Frequent Relapses If you’ve had a lot of episodes of psychotic or mood disturbances because you didn’t take your medicine, LAIs might be a good choice.
    Severity of Symptoms If you have really bad symptoms that make it hard to take your daily medicine, LAI's might be a better option.
    Cognitive Impairment If you have trouble remembering to take your medicine because of your thinking skills, LAI's might be a better option.
    Patient Preference Some people might prefer an injection every few weeks over daily tablets.
    Lack of Insight If you don’t fully understand your illness or why you need medication, LAI's might be a better option.
    Key Points Description
    Definition and Mechanism Specialized formulations of antipsychotic medications providing sustained therapeutic effects with fewer dosing intervals.
    Importance in Medication Adherence Improve adherence by reducing administration frequency and ensuring steady drug levels.
    Beneficiaries Patients with psychiatric illnesses like schizophrenia or bipolar disorder facing medication adherence challenges.
    Medical Indication Management of severe psychiatric conditions, including schizophrenia, bipolar disorder, and schizoaffective disorder.
    Treatment Benefits Reduced symptoms, stabilized mood and behavior, prevented relapse, and improved overall functionality.
    Patient Selection Criteria Patients with poor adherence history, frequent relapses, severe symptoms, cognitive impairment, patient preference, or lack of insight
    Early Intervention Benefits Improved long-term outcomes for early-stage schizophrenia patients.
    Transition Support Smoother transition from hospital to community care with reduced relapse risk.
    Caregiver Support Easier medication management and reduced caregiver burden..

    Summary of Scientific Evidence Regarding LAI's

    Parameter Details Source
    Number of Studies 42 cohort studies academic. oup.com
    Number of Participants 101,624 participants academic. oup.com
    Follow-Up Duration Approximately 18.6 months academic. oup.com
    Baseline Characteristics Greater illness severity and chronicity in LAI group academic. oup.com
    LAI Types First-generation (e.g., fluphenazine decanoate) and second-generation (e.g., risperidone, paliperidone) academic. oup.com
    Duration and Dosage Minimum follow-up of 24 weeks, some >18 months academic. oup.com
    Hospitalization Rate Reduction 15% reduction (Rate Ratio: 0.85; 95% CI: 0.78–0.93; P < .001) academic. oup.com
    Burden of Illness Reduction in hospitalization burden indicated academic. oup.com
    Repeat Hospitalization Reduction Effective in reducing hospitalization rates academic. oup.com

    Illness Specific Data for LAI’s

    Condition Number of Studies/Participants Baseline Characteristics LAI Types and Dosage Duration Effectiveness Outcomes Impact on Burden of Illness Cost Reduction Repeat Hospitalization Reduction Antipsychotic Equivalency
    Schizophrenia 42 studies, 101,624 participants Severe symptoms, chronic illness history, high non-adherence First-gen (fluphenazine), second-gen (risperidone, paliperidone) Min 24 weeks, some >18 months Lower relapse rates, improved adherence, fewer hospitalizations Reduced admissions, better long-term outcomes Lower hospitalization and crisis costs Significant reduction Not uniformly reported
    Bipolar Disorder Limited direct studies, but suggests efficacy Manic and depressive episodes, non-adherence risk Limited data, aripiprazole LAI promising Varied, often shorter trials Stabilized mood, reduced relapses Improved quality of life, fewer severe episodes Potential cost benefits Reduced manic/depressive admissions Aripiprazole-based studies show some equivalency
    Schizoaffective Disorder Fewer studies, data from schizophrenia studies Mood and psychotic symptoms overlap Varies, often aligns with schizophrenia regimens Long-term studies limited Improved mood and psychotic symptoms, reduced hospitalizations Better symptom control, lower caregiver burden Anticipated cost savings Moderate evidence, more research needed Varies by medication
    Condition Number of Studies/Participants Baseline Characteristics LAI Types and Dosage Duration Effectiveness Outcomes Side Effects Impact on Burden of Illness Cost Reduction Repeat Hospitalization Reduction ECT Trial Antipsychotic Equivalency
    Condition Schizophrenia
    Number of Studies/Participants 42 studies, 101,624 participants
    Baseline Characteristics Severe symptoms, chronic illness history, high non-adherence
    LAI Types and Dosage First-gen (fluphenazine), second-gen (risperidone, paliperidone)
    Duration Min 24 weeks, some >18 months
    Effectiveness Outcomes Lower relapse rates, improved adherence, fewer hospitalizations
    Impact on Burden of Illness Reduced admissions, better long-term outcomes
    Cost Reduction Lower hospitalization and crisis costs
    Repeat Hospitalization Reduction Significant reduction
    Antipsychotic Equivalency Not uniformly reported
    Condition Bipolar Disorder
    Number of Studies/Participants Limited direct studies, but suggests efficacy
    Baseline Characteristics Manic and depressive episodes, non-adherence risk
    LAI Types and Dosage Limited data, aripiprazole LAI promising
    Duration Varied, often shorter trials
    Effectiveness Outcomes Stabilized mood, reduced relapses
    Impact on Burden of Illness Improved quality of life, fewer severe episodes
    Cost Reduction Potential cost benefits
    Repeat Hospitalization Reduction Reduced manic/depressive admissions
    Antipsychotic Equivalency Aripiprazole-based studies show some equivalency
    Condition Schizoaffective Disorder
    Number of Studies/Participants Fewer studies, data from schizophrenia studies
    Baseline Characteristics Mood and psychotic symptoms overlap
    LAI Types and Dosage Varies, often aligns with schizophrenia regimens
    Duration Long-term studies limited
    Effectiveness Outcomes Improved mood and psychotic symptoms, reduced hospitalizations
    Impact on Burden of Illness Better symptom control, lower caregiver burden
    Cost Reduction Anticipated cost savings
    Consult Best Psychiatrist in Ahmedabad

    Consultation Timing

    Monday - Saturday
    Morning: 9:00 -1:00 PM
    Evening: 4:00 - 7:00 PM

    Follow Us
    Facebook-f Instagram X-twitter Linkedin Youtube

    Quick Links

    Get In Touch

    Parth Hospital,
    3rd Floor Sigma Excellence, Near Management Enclave, Opposite Falguni Gruh Udyog, Ahmedabad, 380015

    For Appointment

    (91) 972 420 1332
    (91) 987 972 5516

    info@parthhospital.com

    Visit Us

    © 2025 Parth Hospital – All Rights Reserved | Powered By CreativeKatta